Evogene Stock Target Price and Analyst Consensus
EVGN Stock | ILA 602.20 18.60 3.19% |
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Evogene price targets
Evogene's stock target price is an estimate of its future price, usually made by analysts. Using Evogene's target price to determine if it is a suitable investment can be done through the following steps:- Look at Evogene's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Evogene's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Evogene Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Evogene is a key component of Evogene valuation and have some predictive power on the future returns of a Evogene.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Macroaxis Index Invested few shares | ||
Adviser Favorites Invested few shares | ||
Cash Cows Invested few shares | ||
Momentum Invested over 50 shares | ||
FinTech Invested over 60 shares | ||
Business Services Invested few shares | ||
Investor Favorites Invested over 200 shares | ||
Artificial Intelligence Invested few shares | ||
Hedge Favorites Invested over 40 shares | ||
Social Domain Invested few shares |
Additional Information and Resources on Investing in Evogene Stock
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:Check out Macroaxis Advice on Evogene to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Please note, the presentation of Evogene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evogene's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Evogene's management manipulating its earnings.